Efficacy of pegylated interferon‐α2a monotherapy in Japanese children with chronic hepatitis C

Efficacy of pegylated interferon‐α2a monotherapy in Japanese children with chronic hepatitis C
复制标题

聚乙二醇化干扰素α2a单药治疗日本慢性丙型肝炎儿童的疗效

DOI：
--
复制
发表时间：
2011
期刊：
Hepatology Research
影响因子：
4.2
通讯作者：
T. Fujisawa
T. Fujisawa
中科院分区：
医学2区
文献类型：
--
作者：
Tomoyuki Tsunoda;A. Inui;Y. Etani;Yuki Kiyohara;Tokio Sugiura;Koichi Ito;R. Miyazawa;I. Nagata;S. Ida;T. Fujisawa

文献摘要

相似文献

目的：关于聚乙二醇干扰素（PEG IFN）治疗儿童慢性丙型肝炎的疗效信息很少。 本研究的目的是评估PEG IFN-α2a单药治疗慢性丙型肝炎病毒（HCV）感染儿童的疗效和耐受性。
Aim:  There is little information available on the efficacy of pegylated interferon (PEG IFN) therapy for children with chronic hepatitis C. The aim of this study was to evaluate the efficacy and tolerability of PEG IFN‐α2a monotherapy for children infected by chronic hepatitis C virus (HCV).